Peliosis Hepatis Induced by Tamoxifen Therapy in a Patient with Breast Cancer.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
추출되지 않음
I · Intervention 중재 / 시술
multimodal treatment including surgery, chemotherapy, radiation, and endocrine therapy
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
After the discontinuation of tamoxifen treatment, the lesion gradually decreased in size. Although tamoxifen-induced peliosis hepatis is rare, it should be considered in the differential diagnosis of hepatic lesions.
We herein report a case of peliosis hepatis induced by tamoxifen therapy in breast cancer.
APA
Narusawa E, Kodama S, et al. (2026). Peliosis Hepatis Induced by Tamoxifen Therapy in a Patient with Breast Cancer.. Internal medicine (Tokyo, Japan). https://doi.org/10.2169/internalmedicine.6930-25
MLA
Narusawa E, et al.. "Peliosis Hepatis Induced by Tamoxifen Therapy in a Patient with Breast Cancer.." Internal medicine (Tokyo, Japan), 2026.
PMID
41850840 ↗
Abstract 한글 요약
We herein report a case of peliosis hepatis induced by tamoxifen therapy in breast cancer. A woman in her 50s underwent multimodal treatment including surgery, chemotherapy, radiation, and endocrine therapy. One year after surgery, imaging revealed a 3-cm hepatic lesion. The tumor marker levels were mostly normal. A biopsy showed blood-filled cavities without fibrosis, and CD34 staining suggested collapsed sinusoidal structures, leading to a diagnosis of peliosis hepatis. After the discontinuation of tamoxifen treatment, the lesion gradually decreased in size. Although tamoxifen-induced peliosis hepatis is rare, it should be considered in the differential diagnosis of hepatic lesions.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Early local immune activation following intra-operative radiotherapy in human breast tissue.
- Overall survival and prognostic factors in young women with breast cancer: a retrospective cohort study from Southern Thailand.
- Age at First Pregnancy, Adult Weight Gain and Postmenopausal Breast Cancer Risk: The PROCAS Study (United Kingdom).
- Advances in Targeted Therapy for Human Epidermal Growth Factor Receptor 2-Low Tumors: From Trastuzumab to Antibody-Drug Conjugates.
- Structural determinants of glycosaminoglycan oligosaccharides as LL-37 inhibitors in breast cancer.
- Artificial intelligence and breast cancer screening in Serbia: a dual-perspective qualitative study among radiologists and screening-aged women.